“Amphiregulin Modifies The Minnesota Acute Graft-Versus-Host Disease Risk Score: Results From Bmt Ctn 0302/0802.”. Blood Adv 2 (15). Blood Adv: 1882-1888. doi:10.1182/bloodadvances.2018017343.
. 2018. “Factors Associated With Successful Discontinuation Of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation.”. Jama Oncol. Jama Oncol. doi:10.1001/jamaoncol.2019.2974.
. 2019. “Randomized Multicenter Trial Of Sirolimus Vs Prednisone As Initial Therapy For Standard-Risk Acute Gvhd: The Bmt Ctn 1501 Trial.”. Blood 135 (2). Blood: 97-107. doi:10.1182/blood.2019003125.
. 2020. “Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, And Cyclophosphamide; Tacrolimus, Methotrexate, And Bortezomib; Or Tacrolimus, Methotrexate, And Maraviroc) Versus Tacrolimus And Methotrexate For Prevention Of Graft-Versus-Host Disease With”. Lancet Haematol 6 (3). Lancet Haematol: e132-e143. doi:10.1016/S2352-3026(18)30221-7.
. 2019.